Featuring an interview with Dr Patrick Y Wen, including the following topics:
- Glioma classification (0:00)
- Efficacy and safety of vorasidenib in the management of IDH-mutant gliomas (4:50)
- Case: A woman in her early 30s with a Grade 2 astrocytoma and an IDH R132H mutation and residual disease postoperatively (11:55)
- Case: A man in his early 40s experiencing stable disease with vorasidenib after subtotal resection (21:46)
- Ongoing trial investigating vorasidenib in IDH-mutant gliomas (27:30)
- Current and emergent strategies for the management of glioblastoma (31:27)
- Optimizing patient care and quality of life (46:24)
CME information and select publications
Research To Practice | Oncology Videos